Lewis Brisbois, Weil Guide $335M Cancer Biotech SPAC Deal
Clinical-stage biotechnology company Calidi Biotherapeutics and special-purpose acquisition company First Light announced on Monday that they entered into a merger agreement to create a public company worth $335 million focused on...To view the full article, register now.
Already a subscriber? Click here to view full article